Back to category hubs

CATEGORY HUB

Endogenous peptide or physiological peptide signal

This hub separates regulatory meaning from marketing shorthand. Registered, listed, submitted, compounded, cosmetic-listed, or research-use-only does not automatically mean FDA-approved.

Registered is not approved

PeptiLens treats regulatory terms as source-specific facts, not broad claims of safety, legality, or efficacy.

DMF submitted is not approved

PeptiLens treats regulatory terms as source-specific facts, not broad claims of safety, legality, or efficacy.

Cosmetic listed is not clinically proven

PeptiLens treats regulatory terms as source-specific facts, not broad claims of safety, legality, or efficacy.

Matching entries

PeptideEvidenceRegulatorySafetyReviewed
ACTH
Adrenocorticotropic hormone peptide
CUnknown2/56/23/2026
Adropin
Metabolic peptide hormone
CUnknown2/56/23/2026
Amylin
Pancreatic peptide hormone
CUnknown2/56/23/2026
Atrial natriuretic peptide
Cardiac natriuretic peptide
CUnknown2/56/23/2026
Calcitonin gene-related peptide
Neuropeptide
CUnknown2/56/23/2026
CRH
Corticotropin-releasing hormone
CUnknown2/56/23/2026
C-type natriuretic peptide
Natriuretic peptide
CUnknown2/56/23/2026
Dynorphin
Endogenous opioid peptide
CUnknown2/56/23/2026
Enkephalin
Endogenous opioid peptide
CUnknown2/56/23/2026
Galanin
Neuropeptide
CUnknown2/56/23/2026
GIP
Incretin peptide hormone
CUnknown2/56/23/2026
GLP-1
Incretin peptide hormone
CUnknown2/56/23/2026
GLP-2
Gut peptide hormone
CUnknown2/56/23/2026
Humanin
Mitochondrial-derived peptide
CUnknown2/56/23/2026
Nesfatin-1
Satiety-associated peptide
CUnknown2/56/23/2026
Neurotensin
Neuropeptide
CUnknown2/56/23/2026
Orexin-A
Wakefulness neuropeptide
CUnknown2/56/23/2026
SHLP-2
Mitochondrial-derived peptide
CUnknown2/56/23/2026
Somatostatin
Inhibitory peptide hormone
CUnknown2/56/23/2026
Substance P
Tachykinin neuropeptide
CUnknown2/56/23/2026
TRH
Thyrotropin-releasing hormone
CUnknown2/56/23/2026
Urocortin
CRH-family peptide
CUnknown2/56/23/2026